Science and society - Models for facilitating access to patents on genetic inventions

被引:48
作者
Van Overwalle, G [1 ]
van Zimmeren, E
Verbeure, B
Matthijs, G
机构
[1] Katholieke Univ Leuven, Fac Law, Ctr Intellectual Property Rights, Louvain, Belgium
[2] Katholieke Univ Leuven, Fac Med, Ctr Human Genet, Louvain, Belgium
关键词
D O I
10.1038/nrg1765
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The genetics community is increasingly concerned that patents might lead to restricted access to research and health care. We explore various measures that are designed to render patented genetic inventions accessible to further use in research, and to diagnosis and/or treatment. They include the often-recited research or experimental-use exemption, conventional one-to-one licensing and compulsory licensing, as well as patent pools and clearing-house mechanisms. The last two alternatives deserve special attention in the area of human genetics.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 40 条
[1]  
Abbott F. M., 2002, The Journal of World Intellectual Property, V5, P15
[2]  
[Anonymous], 1998, COMMUNICATION
[3]  
[Anonymous], EXPANDING BOUNDARIES
[4]  
[Anonymous], 2002, ETH PAT DNA DISC PAP
[5]  
*AUSTR LAW REF COM, 2004, 68 AUSTR LAW REF COM
[6]   Golden rice:: Introducing the β-carotene biosynthesis pathway into rice endosperm by genetic engineering to defeat vitamin A deficiency [J].
Beyer, P ;
Al-Babili, S ;
Ye, XD ;
Lucca, P ;
Schaub, P ;
Welsch, R ;
Potrykus, I .
JOURNAL OF NUTRITION, 2002, 132 (03) :506S-510S
[7]  
Carlson S.C., 1999, Yale Journal on Regulation, V16, P359
[8]  
CHROCZIEL P, 1986, BENUTZUNG PATENTIERT
[9]  
*CIPP, 2004, CTR INT PROP POL PUB
[10]  
CLARK J, 2000, US PATENT TRADEMARK